Tong Kan

427 total citations
15 papers, 359 citations indexed

About

Tong Kan is a scholar working on Hepatology, Cancer Research and Surgery. According to data from OpenAlex, Tong Kan has authored 15 papers receiving a total of 359 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Hepatology, 7 papers in Cancer Research and 6 papers in Surgery. Recurrent topics in Tong Kan's work include Hepatocellular Carcinoma Treatment and Prognosis (7 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (3 papers) and Liver physiology and pathology (3 papers). Tong Kan is often cited by papers focused on Hepatocellular Carcinoma Treatment and Prognosis (7 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (3 papers) and Liver physiology and pathology (3 papers). Tong Kan collaborates with scholars based in China, Colombia and United States. Tong Kan's co-authors include Jiamei Yang, Ningjia Shen, Bin Yi, Yongjie Zhang, Yongpeng Wei, Wenlong Yu, Yanming Zhou, Bin Li, Chengjun Sui and Bin Wang and has published in prestigious journals such as PLoS ONE, Biochemical and Biophysical Research Communications and Frontiers in Microbiology.

In The Last Decade

Tong Kan

14 papers receiving 355 citations

Peers

Tong Kan
Tong Kan
Citations per year, relative to Tong Kan Tong Kan (= 1×) peers YiJiang Song

Countries citing papers authored by Tong Kan

Since Specialization
Citations

This map shows the geographic impact of Tong Kan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tong Kan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tong Kan more than expected).

Fields of papers citing papers by Tong Kan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tong Kan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tong Kan. The network helps show where Tong Kan may publish in the future.

Co-authorship network of co-authors of Tong Kan

This figure shows the co-authorship network connecting the top 25 collaborators of Tong Kan. A scholar is included among the top collaborators of Tong Kan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tong Kan. Tong Kan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Kan, Tong, et al.. (2022). In vitro Susceptibility of Human Cell Lines Infection by Bovine Leukemia Virus. Frontiers in Microbiology. 13. 793348–793348. 6 indexed citations
2.
Lou, Zhen, et al.. (2020). Effects of permeability anisotropy on coal mine methane drainage performance. Journal of Natural Gas Science and Engineering. 86. 103733–103733. 30 indexed citations
3.
Hu, Jianzhang, et al.. (2017). Inhibition of Fusarium solani Infection in Murine Keratocytes by Lactobacillus salivarius ssp. salivarius JCM1231 Culture Filtrate In Vitro. Current Eye Research. 42(10). 1339–1347. 6 indexed citations
4.
Huang, Yangqing, et al.. (2014). Liver‐to‐Spleen Ratio as an Index of Chronic Liver Diseases and Safety of Hepatectomy: A Pilot Study. World Journal of Surgery. 38(12). 3186–3192. 8 indexed citations
5.
Luo, Xiangji, Tong Kan, Yongjie Zhang, et al.. (2013). TGF-β upregulates miR-182 expression to promote gallbladder cancer metastasis by targeting CADM1. Molecular BioSystems. 10(3). 679–685. 47 indexed citations
6.
Wei, Yongpeng, Ningjia Shen, Tong Kan, et al.. (2013). miR-204 Inhibits Epithelial to Mesenchymal Transition by Targeting Slug in Intrahepatic Cholangiocarcinoma Cells. Cellular Physiology and Biochemistry. 32(5). 1331–1341. 84 indexed citations
7.
Huang, Yangqing, Helin Feng, Tong Kan, et al.. (2013). Bevacizumab Attenuates Hepatic Fibrosis in Rats by Inhibiting Activation of Hepatic Stellate Cells. PLoS ONE. 8(8). e73492–e73492. 40 indexed citations
8.
Yang, Jiamei, Chengjun Sui, Tong Kan, Bin Li, & Yanming Zhou. (2013). Infrahepatic inferior vena cava clamping in hepatectomy for tumors involving hepatocaval confluence. Asian Journal of Surgery. 36(3). 111–115. 6 indexed citations
9.
Zhou, Yanming, Chengjun Sui, Bin Li, et al.. (2012). Results of en bloc resection for hepatocellular carcinoma extending to adjacent organs. Canadian Journal of Surgery. 55(4). 222–226. 12 indexed citations
10.
Zhou, Yanming, Chengjun Sui, Bin Li, et al.. (2011). Safety and efficacy of trisectionectomy for hepatocellular carcinoma. ANZ Journal of Surgery. 81(12). 895–899. 10 indexed citations
11.
Geng, Li, Bin Zhu, Binghua Dai, et al.. (2011). A let-7/Fas double-negative feedback loop regulates human colon carcinoma cells sensitivity to Fas-related apoptosis. Biochemical and Biophysical Research Communications. 408(3). 494–499. 34 indexed citations
12.
Zhou, Yanming, Jiamei Yang, Bin Li, et al.. (2010). Risk factors for early recurrence of small hepatocellular carcinoma after curative resection.. PubMed. 9(1). 33–7. 63 indexed citations
13.
Fan, Fei, Eric C. H. Lai, Jiamei Yang, et al.. (2010). Intraductal papillary mucinous neoplasms of the pancreas--predictors of malignancy.. PubMed. 57(99-100). 635–9. 4 indexed citations
14.
Yang, Jiamei, Ying Tong, Feng Xu, et al.. (2007). [Study of bloodless hepatectomy under occlusion of total hemi-hepatic vessel].. PubMed. 45(3). 186–8.
15.
Yang, Jiamei, Tong Kan, Han Chen, & Meng-Chao Wu. (2002). Hepatectomy in the treatment of very big primary liver cancer: report of 86 cases.. PubMed. 1(1). 42–5. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026